Insulin-like growth factor 2 (IGF-2), an upstream activator of the PI3K/AKT pathway, was increased by lncRNAs NEAT1 and GM15290 to enhance NSCLC cell proliferation, invasion, and migration. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.